King's College London

Research portal

Use of pentoxifylline and tocopherol in the management of osteoradionecrosis

Research output: Contribution to journalArticle

Vinod Patel, Yusuf Gadiwalla, Isabel Sassoon, Chris Sproat, Jerry Kwok, Mark McGurk

Original languageEnglish
Pages (from-to)342-345
JournalBritish Journal of Oral and Maxillofacial Surgery
Issue number3
Early online date19 Jan 2016
Publication statusPublished - Apr 2016

King's Authors


Osteoradionecrosis (ORN) is a complication of radiotherapy, and is difficult to manage once established. However, its pathogenesis has been reinvestigated, and it is now thought to be potentially amenable to treatment with pentoxifylline and tocopherol (vitamin E). We made a retrospective analysis of 62 patients with established ORN who were treated in this way. When only pentoxifylline and vitamin E was used ORN resolved in 14/25 (56%) but paradoxically, when it was combined with antibiotics, only 6/22 resolved (27%). The next stage would ideally be to incorporate the treatment in a randomised clinical trial against both standard antibiotic treatment and hyperbaric oxygen.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454